Internationally Recognized Urologist, Robotic Surgeon and Researcher Dr. Andrew J. Stephenson Joins Associated Medical Professionals of NY

Associated Medical Professionals of NY (A.M.P.) is pleased to announce that Andrew J. Stephenson, MD, MBA, FACS, FRCS(C) has joined its care team. Specialty trained in urologic oncology and robotics, Dr. Stephenson has vast experience in diagnosing and treating urologic cancers using the latest minimally invasive technologies and more conventional approaches. Dr. Stephenson has performed more than 2,000 robotic urology surgeries in his career.

Associated Medical Professionals of NY is a leading multi-specialty practice spanning 19 locations in Central New York, including ten offices and nine hospitals. A.M.P. is an affiliate of U.S. Urology Partners, one of the largest independent providers of urological and specialty related services in the nation, which is backed by NMS Capital.

Christopher M. Pieczonka, MD, Chief Executive Officer of Associated Medical Professionals of NY and Corporate Director of Clinical Research of U.S. Urology Partners, stated, “A.M.P. is very proud to have Dr. Andrew Stephenson join our practice. We are so excited to welcome a world renown expert and former Director of Urologic Oncology at the Cleveland Clinic to enhance and elevate the care of our local cancer patients. We look forward to the new skills and expertise that Dr. Stephenson will contribute that will put us on par with National Cancer Institute designated cancer centers.”

Dr. Andrew Stephenson said, “I am committed to excellence in patient care, research and innovations in urology. I am excited to join the team at A.M.P. as it provides me an opportunity to deliver innovative, compassionate and high-quality care to patients with complex urological problems, including cancers of the prostate, bladder, kidney and testis, BPH and prostate problems, and PSA screening. I am honored to join a team of like-minded and skilled professionals who are aligned in A.M.P.’s goals: to deliver world-class and comprehensive urological care to the people of the Syracuse community and upstate New York.”

“I am passionate about urological problems and the care of my patients. I endeavor to be my best every day for my patients. I have an unwavering commitment to developing and adopting the most effective treatments for my patients and advancing the field for future patients through clinical trials,” said Dr. Stephenson. “The state-of-the-art facilities at A.M.P. will enable me to deliver the most advanced and innovative urological care for my patients. We endeavor to be at the forefront of urological care, offering patients the spectrum of medical and surgical treatment for their urological problems.”

To learn more about Dr. Stephenson and A.M.P. or to schedule an appointment, please visit www.ampofny.com, www.ampofny.com/physicians/andrew-j-stephenson-md/ or call (315) 478-4185.                                                                                                                                                                                             

About Dr. Andrew J. Stephenson

Andrew J. Stephenson, MD, MBA, FACS, FRCS(C) is an internationally recognized urologist, robotic surgeon and researcher. Before joining Associated Medical Professionals of NY, he served as Director of Urologic Oncology at Rush University Medical Center, Director of the Center of Urologic Oncology at Cleveland Clinic’s Glickman Urological and Kidney Institute and a staff member of the Taussig Cancer Institute. His clinical and research focus is on the treatment of patients with cancers of prostate, bladder and testis. He has published over 125 articles in peer-reviewed journals since 2002 on issues related to prostate, bladder and testis cancer, many of which have received international mainstream media attention. He has been invited to speak on these subjects at major international medical conferences.

Dr. Stephenson is board-certified in urology by the American Board of Urology and the Royal College of Physicians and Surgeons of Canada. He has received several awards from organizations such as the Prostate Cancer Foundation, American Society of Clinical Oncology and Society of Urologic Oncology. He is listed as one of the Best Doctors in America. He received the Urology Teacher of the Year award while at Rush University and Cleveland Clinic.

Dr. Stephenson has received grant support for prostate cancer research from the Robert Wood Johnson Foundation. His research focus is on the development of prognostic statistical models called nomograms. These prognostic models provide accurate predictions of treatment outcome for prostate cancer and are widely used for patient counseling. He is on the editorial board for several urology journals, including Urology, and is an ad hoc reviewer for Journal of the National Cancer Institute, Journal of Clinical Oncology and Journal of Urology.

For patients with prostate cancer, Dr. Stephenson performs both nerve-sparing robotic prostatectomy using latest state-of-art approaches. The decision to perform either robotic or open prostatectomy is tailored to the specifics of each patient’s cancer and preferences. For patients with bladder cancer, Dr. Stephenson also performs robotic nerve-sparing radical cystectomy and orthotopic urinary diversion (neobladder or Studer) for both men and women. He is highly skilled on minimally invasive robotic approaches for kidney tumors and advanced kidney cancers. For select patients with testicular cancer, Dr. Stephenson performs robotic nerve-sparing lymph node dissection. He also has vast experience in minimally invasive treatments for BPH and voiding dysfunction. He has also been a pioneer in the development of biomarkers and image-guided diagnostic approaches for prostate cancer diagnosis and treatment.

About Associated Medical Professionals of NY (A.M.P.)

Associated Medical Professionals of New York (A.M.P.) is a multi-specialty medical practice based in Syracuse serving the Central New York region. Established in 2008, A.M.P. has grown to become one of the largest multi-specialty groups of its kind in the area that strives to provide quality care at each of its ten offices and nine hospital locations. As a pivotal point of care in each community, A.M.P. is able to provide continuity of care for a vast population of patients. A.M.P. maintains a robust suite of services, including advanced urological care, robotic surgery, cancer care, radiation oncology, pathology, lithotripsy, imaging and clinical research. A.M.P. is an affiliate of U.S. Urology Partners, one of the largest independent providers of urological and related specialty services in the nation, which is backed by NMS Capital. For more information, visit www.ampofny.com and www.us-uro.com.

U.S. Urology Partners Announces Partnership with Greater Boston Urology

NMS Capital portfolio company U.S. Urology Partners is pleased to announce that Greater Boston Urology (GBU) has joined its national network of affiliate urology practices. U.S. Urology Partners’ network now encompasses over 150 providers operating throughout over 60 clinical locations in five states.

Greater Boston Urology is a market-leading, multi-specialty urology practice serving Boston and the surrounding regions. Operating throughout Massachusetts via a provider base of over 20 physicians and 10 Advanced Practice providers, Greater Boston Urology is the largest urology group within the state of Massachusetts and maintains a longstanding history and track record of premier patient care and outcomes, a combination which in turn affords GBU its market leadership position.

The affiliation marks U.S. Urology Partners’ fifth partnership of significant scale since partnering with NMS and expands the broader platform’s geographic footprint into a fifth state. In addition, the transaction further cements U.S. Urology Partners’ leadership position as one of the nation’s largest independent providers of urological care and other specialty services. U.S. Urology Partners is led and supported by a premier, purpose-built executive management team with deep experience and expertise building and growing multi-site healthcare services platforms.

Corina Tracy, CEO of U.S. Urology Partners, commented, “U.S. Urology Partners maintains a track record of partnering with premier, market-leading integrated urology practices of significant scale. As such, our transaction with Greater Boston Urology fits these criteria perfectly and represents a seamless continuation of our past strategies. As we continue to grow and expand as a platform, the team and I at U.S. Urology Partners remain excited and enthusiastic by the prospects for future growth and efficiency made available to us. We look forward to welcoming Greater Boston Urology to the U.S. Urology Partners family and executing upon our common goals and aims together.”

Dr. Michael Curran, Greater Boston Urology President, noted, “We are thrilled to be joining forces with U.S. Urology Partners and are excited by the prospects of aligning with a leading, national platform within the urology market. Our choice to partner with U.S. Urology Partners was fueled by our shared commitment to patient outcomes and vision for growth, and we look forward to executing upon our next chapter of success together.”

Luis Gonzalez, Senior Partner at NMS Capital, said, “U.S. Urology Partners’ partnership with Greater Boston Urology marks the fifth of significant scale since we partnered together to form a best-in-class urological platform. Throughout that time, U.S. Urology Partners has grown to represent one of the largest integrated urology practices in the country driven by a combination of organic and acquisition-centric strategies.”

McDermott Will & Emery provided legal advice to U.S. Urology Partners and NMS. Financing for the transaction was provided by Twin Brook Capital Partners and Crescent Capital. Stifel Nicolaus & Company served as financial advisor and Katten Muchin Rosenman provided legal advice to Greater Boston Urology.

About U.S. Urology Partners

U.S. Urology Partners is one of the nation’s largest independent providers of urology and other specialty services, including general urology, surgical procedures, advanced treatment options for prostate and bladder cancer, and other ancillary services. The practice consists of over 150 providers across a network of over 60 locations throughout Ohio, New York, Florida, Indiana and Massachusetts including two ambulatory surgery centers as well as a state-of-the-art robotic surgery function. For additional information on U.S. Urology Partners, please visit our website at www.us-uro.com.

About NMS Capital

Founded in 2010, NMS Capital is an experienced private equity firm managing assets in excess of $1.4 billion. Since inception, NMS has partnered with management teams in over 100 investments and follow-on acquisitions across defined investment themes within the Business Services and Healthcare Services industries. The firm’s principal strategy is to create long-term value by providing strategic and operational resources to growth-oriented companies led by founders or experienced management teams. NMS has successfully built industry leading lower middle market companies in defensible and scalable end markets by accelerating organic and acquisition-driven growth. For additional information on NMS, please visit the firm’s website at www.nms-capital.com.

U.S. Urology Partners Announces Partnership with Associated Medical Professionals of New York

U.S. Urology Partners, a portfolio company of NMS Capital, announced today its strategic partnership with Associated Medical Professionals of New York, creating one of the nation’s largest independent providers of urological and other specialty services. Terms of the transaction were not disclosed.

Associated Medical Professionals is a market-leading, multi-specialty urology practice operating throughout Syracuse, New York, and the surrounding regions. U.S. Urology Partners’ operations include one of the largest urology practices in the Midwest, Central Ohio Urology Group. The combined groups will benefit from U.S. Urology Partners’ substantial investment in people, technology and services to better address patient and employee needs in the communities they serve, while being well positioned for continued growth.

“We are excited about the synergies and strengths this new partnership brings to U.S. Urology Partners,” stated Mark Cherney, Chief Executive Officer, U.S. Urology Partners. “It’s the next step in building our platform into a world-class urology services model that provides a better patient, physician and employee experience in the communities we serve. We believe that this partnership will deliver best practices and outcomes that will lead the urological industry for decades to come.”

Dr. Angelo R. DeRosalia, Chairman and Chief Executive Officer of Associated Medical Professionals, and newly appointed U.S. Urology Partners President, commented, “This exciting partnership will allow Associated Medical Professionals to remain at the forefront as a premier provider of quality, compassionate healthcare. We are looking forward to our patients experiencing the benefits offered by U.S. Urology Partners.”

Luis Gonzalez, Partner at NMS Capital, added, “The addition of Associated Medical Professionals is a transformative partnership for U.S. Urology Partners, and along with the investment in Central Ohio Urology Group, creates a clear leader in the urology space. The transaction sends a strong signal to the market that U.S. Urology Partners has a truly differentiated approach to working with urology groups, and NMS’s track-record of successfully building market-leading practices across numerous physician specialties is an equally important factor.”

U.S. Urology Partners provides extensive leadership expertise and infrastructure resources across important functional areas, including provider recruitment, payor contracting, data analytics, compliance and business development to enhance the patient, physician and employee experience.

Nexus Health Capital served as financial advisor and Katten Muchin Rosenman provided legal advice to Associated Medical Professionals. McDermott Will & Emery and Greenberg Traurig provided legal advice to NMS and U.S. Urology Partners.

About U.S. Urology Partners

U.S. Urology Partners is one of the nation’s largest independent providers of urology and other specialty services, including general urology, surgical procedures, advanced treatment options for prostate and bladder cancer, and other ancillary services. The practice now consists of more than 50 providers across a clinical network with 24 offices throughout central Ohio and upstate New York, including a state-of-the-art ambulatory surgery center. U.S. Urology Partners was formed to support urology practices through an experienced team of healthcare executives and resources, while serving as a platform upon which NMS Capital intends to build a leading provider of urological services through an acquisition strategy. U.S. Urology Partners’ corporate offices are in Gahanna, Ohio, and Nolensville, Tennessee, just outside of Columbus and Nashville. For additional information on U.S. Urology Partners, please visit the company’s website at www.us-uro.com.

About Associated Medical Professionals of New York

Associated Medical Professionals of New York (“AMP”) is a multi-specialty medical practice based in Syracuse, New York, serving the Central New York region. Established in 2008, AMP has grown to become one of the largest multi-specialty groups of its kind in the area that strives to provide quality healthcare at each of the nine locations. As a pivotal point of care in each community, AMP is able to provide continuity of care for a vast population of patients. AMP maintains a robust suite of ancillary services, including radiation oncology, pathology, lithotripsy, imaging and clinical research. AMP’s provider base consists of more than 30 providers and numerous clinical support staff practicing in nine office locations. For more information on Associated Medical Professionals, please visit the company’s website at www.ampofny.com.

About NMS Capital

NMS Capital is a New York headquartered private investment firm specializing in strategic equity investments and leveraged buyouts of lower middle market companies. The firm was formed through the spin-out of a group of portfolio companies from the Goldman Sachs Merchant Banking Division. NMS focuses on companies headquartered in the U.S. poised to benefit from sustainable growth trends with particular concentration on companies in Business Services and Healthcare Services. For additional information on NMS Capital, please visit the firm’s website at www.nms-capital.com.

Dr. Jonathan J. Corbett Joins Central Ohio Urology Group

Central Ohio Urology Group (COUG) is pleased to announce that Jonathan J. Corbett, M.D., has joined the practice. Through a network of 15 offices in the region, Central Ohio Urology Group is one of the nation’s leading providers of comprehensive urological services, including men’s health, women’s health, cancer care, advanced treatment options for prostate and bladder cancer, and radiation oncology. COUG’s facilities include a urology-specific surgery center, as well as an Advanced Prostate Cancer Clinic. Central Ohio Urology Group is an affiliate of U.S. Urology Partners, which supports urology practices and is backed by NMS Capital.

Mark Cherney, CEO of Central Ohio Urology Group and U.S. Urology Partners, stated, “I am excited to welcome Dr. Corbett to our practice. He provides a great blend of top-notch clinical education and knowledge with a strong passion for providing community-based care. He takes particular interest in co-managing urological conditions with his primary care partners: kidney stones, prostate cancer, general urology, robotics and endourology, to name a few. I also expect that he will be an active member of the community, and that will be evident over the course of the months and years to come.”

Dr. Corbett was born and raised in Cincinnati. He attended The Ohio State University, where he earned his Bachelor of Science in Biology. Dr. Corbett went on to attend Wright State University Boonshoft School of Medicine for his medical degree, where he graduated as a member of both the Alpha Omega Alpha and the Gold Humanism Honor Societies. He completed a residency in Urology at the University of Cincinnati.

“My goal is to manage patients’ urologic issues with as little disruption to their normal lives as possible,” said Dr. Corbett. “Shared decision making is a cornerstone of my practice and important to help patients make the best decisions based on their individual condition and goals. I firmly believe that collaboration between providers on our patients’ healthcare is key to providing the best possible care.”

“My wife and I met during medical school, and we are excited to return to her hometown of Columbus. I share Central Ohio Urology Group’s commitment to serve the community and am honored to join such an outstanding team of caring professionals,” added Dr. Corbett.

Dr. Corbett is now accepting patients and will primarily be working from the group’s offices at 350 W. Wilson Bridge Road, Worthington, OH 43085 and the Central Ohio Urology Surgery Center at 701 Tech Center Drive, Gahanna, OH 43230. Please contact (614) 396-2684 to make an appointment or for additional information.

About Central Ohio Urology Group

Central Ohio Urology Group (COUG) is one of the nation’s leading providers of urological services with a network of 15 offices in the region. Headquartered just outside of Columbus in Gahanna, Ohio, COUG provides comprehensive services, including men’s health, women’s health, cancer care, advanced treatment options for prostate and bladder cancer, and radiation oncology. Central Ohio Urology Group is an affiliate of U.S. Urology Partners, which has plans to support urology practices nationally and is backed by NMS Capital. For more information, visit www.centralohiourology.com and www.us-uro.com.

US Foot & Ankle Specialists Expands Presence in Pennsylvania with the Acquisition of Harrisburg Foot & Ankle Center

US Foot & Ankle Specialists, LLC (“USFAS”), a portfolio company of NMS Capital (“NMS”), announced today that it has acquired Harrisburg Foot & Ankle Center (“HFA” or the “Company”). Headquartered in Harrisburg, Pennsylvania, Harrisburg Foot & Ankle Center has been providing podiatric care through its three locations in Harrisburg, Mechanicsburg and Newport, Pennsylvania since 1995. Dr. Allan Grossman will continue leading the practice with the additional support of USFAS.

“We are very excited to partner with Dr. Allan Grossman and his practice. He and his team have built a great clinical reputation for themselves over the past twenty-four years, and we look forward to having them be a part of the USFAS family as we expand our footprint in Pennsylvania. Our partnership with NMS allows us to continue executing on our stated strategy of partnering with like-minded practices in our existing and adjacent geographies. Our strength and success come from dedicated physician leadership and clinical support staff, who are focused on providing patients with quality care and achieving successful outcomes,” said Brett Richey, Chief Executive Officer of USFAS.

Dr. Allan Grossman added, “I am proud to partner with a leading podiatry platform such as USFAS. The partnership will offer our patients greater support as we experience our next phase of growth. In addition to continuing to receive personal podiatry care from our local podiatrists who place a high value on patient satisfaction and quality care, our patients will benefit from the array of functional support USFAS has to offer them.”

Harrisburg Foot & Ankle Center will maintain its three locations in Harrisburg, Mechanicsburg and Newport, Pennsylvania and continue providing complete podiatry care while benefitting from USFAS’s extensive administrative and support services, including investments in clinical compliance, information technology, electronic medical records, revenue cycle management, payor credentialing and contracting, finance and accounting, human resources and business development.

About US Foot & Ankle Specialists

USFAS is a leading provider of podiatric services providing a full range of specialty services for the advanced treatment of foot and lower extremity conditions through Board Certified and Board Qualified podiatrists. Headquartered in Charlottesville, Virginia, USFAS provides services through a growing network of nearly 40 offices in states including Maryland, Virginia, Pennsylvania, North Carolina and Washington, D.C and over 60 Board Certified podiatrists.

For additional information on USFAS, visit the company’s website at www.footandankle-usa.com.

About NMS Capital

NMS Capital is a New York headquartered private investment firm specializing in strategic equity investments and leveraged buyouts of lower middle market companies.  The Firm was formed through the spin-out of a group of portfolio companies from the Goldman Sachs Merchant Banking Division. NMS focuses on companies headquartered in the U.S. poised to benefit from sustainable growth trends with particular concentration on companies in Healthcare Services and Specialized Business Services.

For additional information on NMS, visit the firm’s website at www.nms-capital.com.

U.S. Urology Partners Expands Senior Management Team; New CFO, CDO Have Extensive Healthcare Backgrounds

U.S. Urology Partners has added two highly experienced healthcare experts to its executive team. Anthony Bond, CPA, has joined the company as Chief Financial Officer, and Chad Baldwin will serve as Chief Development Officer.

U.S. Urology Partners offers an alternative to hospital acquisition, allowing urology practices to retain their independence while benefitting from operational support, management expertise and deep financial resources. Physician partners retain their independence, avoid hospital employment, and drive clinical leadership and patient care.

“We are very pleased to add Anthony and Chad to the U.S. Urology Partners team,” said Mark Cherney, CEO, U.S. Urology Partners. “It’s a testament to the strength of our company as well as our vision for the future that they chose to align with us. They understand and embrace our goal: to enable urologists to focus on clinical care while our skilled experts help optimize other business aspects of the practices.”

Anthony Bond, CPA, is a seasoned financial executive with more than 20 years of experience in the healthcare service sector. Most recently as CFO of IMAC Holdings, a provider of regenerative services as an alternative to surgery, he led the company from cash-based operations through an IPO, taking the company public on the NASDAQ. He previously ran Bond Consulting Group, providing a variety of strategic financial services to organizations while arranging for financing, starting, managing and ultimately selling three businesses. Mr. Bond’s experience includes serving as Group CFO and Vice President for Symbion, an owner of more than 60 ambulatory surgery centers and hospitals; Vice President of Financial Operations for Inspiris, Inc.; and Vice President of National Accounts for Passport Health Communications.

Chad Baldwin is a senior executive with nearly two decades of healthcare services experience in finance, operations and business development. His background includes serving as Vice President of Hospital Operations for Surgery Partners, Inc., an integrated outpatient healthcare company with 180 facilities in 32 states. Mr. Baldwin’s focus was on development and acquisition efforts aimed at surgical hospitals, ambulatory surgery centers, physician practices and urgent care. During his decade with Surgery Partners, Mr. Baldwin served as Vice President of Acquisitions and Development as well as interim Chief Executive Officer of Lubbock Heart and Surgical Hospital. Previously, Mr. Baldwin was a Senior Accountant with Psychiatric Solutions, Inc. as well as Ernst and Young, LLP.

About U.S. Urology Partners

U.S. Urology Partners offers an alternative to hospital acquisition, allowing urology practices to retain their independence while benefitting from operational support, management expertise and deep financial resources of a partner. The strength and experience of U.S. Urology Partners enables practices to concentrate on what they do best – delivering the highest level of care to patients. U.S. Urology Partners is an affiliate of Central Ohio Urology Group and NMS Capital with plans to expand nationally. Learn more at www.us-uro.com.